Smithfield Trust CO Vertex Pharmaceuticals Inc Transaction History

Smithfield Trust CO

$2.04 Billion
Q3 2024

A detailed history of Smithfield Trust CO transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Smithfield Trust CO holds 658 shares of VRTX stock, worth $268,582. This represents 0.02% of its overall portfolio holdings.

Number of Shares

658

Previous 658 -0.0%

Holding current value

$268,582

Previous $307,000 -0.0%

% of portfolio

0.02%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$407.69 - $446.08 $14,676 - $16,058	-36 Reduced 5.19%	658 $276,000
Q4 2023 Feb 07, 2024	SELL	$343.0 - $410.68 $43,218 - $51,745	-126 Reduced 15.37%	694 $280,000
Q2 2023 Aug 08, 2023	BUY	$314.42 - $351.91 $3,144 - $3,519	10 Added 1.23%	820 $288,000
Q1 2023 May 11, 2023	BUY	$283.23 - $323.1 $4,531 - $5,169	16 Added 2.02%	810 $258,000
Q4 2022 Feb 13, 2023	BUY	$285.76 - $321.48 $4,286 - $4,822	15 Added 1.93%	794 $229,000
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $72,017 - $80,354	263 Added 50.97%	779 $225,000
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $3,985 - $4,697	-18 Reduced 3.37%	516 $135,000
Q3 2021 Nov 12, 2021	SELL	$181.39 - $202.99 $4,534 - $5,074	-25 Reduced 4.47%	534 $98,000
Q4 2020 Feb 12, 2021	SELL	$207.01 - $276.09 $84,046 - $112,092	-406 Reduced 42.07%	559 $132,000
Q3 2020 Nov 16, 2020	SELL	$255.65 - $303.1 $16,105 - $19,095	-63 Reduced 6.13%	965 $263,000
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $116,798 - $153,224	518 Added 101.57%	1,028 $299,000
Q1 2020 May 05, 2020	BUY	$199.77 - $247.81 $49,542 - $61,456	248 Added 94.66%	510 $122,000
Q3 2019 Oct 30, 2019	SELL	$166.23 - $187.09 $6,649 - $7,483	-40 Reduced 13.25%	262 $45,000
Q3 2018 Nov 05, 2018	SELL	$167.73 - $192.74 $5,702 - $6,553	-34 Reduced 10.12%	302 $59,000
Q2 2018 Jul 16, 2018	SELL	$145.72 - $169.96 $115,993 - $135,288	-796 Reduced 70.32%	336 $57,000
Q4 2017 Feb 02, 2018	BUY	$137.28 - $155.55 $33,221 - $37,643	242 Added 27.19%	1,132 $170,000
Q3 2017 Nov 03, 2017	BUY	$148.13 - $162.24 $131,835 - $144,393	890	890 $135,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Smithfield Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Smithfield Trust CO with notifications on news.

Account

Smithfield Trust CO Vertex Pharmaceuticals Inc Transaction History